More Combinations like Nivolumab and Ipilimumab Coming for Lung, Bladder, and Kidney Cancer - 102126

Spotlight
Video

More Combinations like Nivolumab and Ipilimumab Coming for Lung, Bladder, and Kidney Cancer

Loading........
Description: Lawrence Fong, MD of University of California, San Francisco discusses the use of more combinations therapies, like Nivolumab and Ipilimumab. This combination therapy is FDA approved for Melanoma, but combination therapies like these may be used for treating new cancers such as Lung, Bladder, and Kidney. This was recorded at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando, Florida.
Shared By : AnnualMeeting-SITC2017
Posted on : 03/06/17
Added : 1 year ago
Category : Other